1. Home
  2. JNJ vs PM Comparison

JNJ vs PM Comparison

Compare JNJ & PM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Johnson & Johnson

JNJ

Johnson & Johnson

HOLD

Current Price

$259.78

Market Cap

542.4B

Sector

Health Care

ML Signal

HOLD

Logo Philip Morris International Inc

PM

Philip Morris International Inc

HOLD

Current Price

$185.71

Market Cap

277.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JNJ
PM
Founded
1886
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
542.4B
277.9B
IPO Year
2003
2007

Fundamental Metrics

Financial Performance
Metric
JNJ
PM
Price
$259.78
$185.71
Analyst Decision
Buy
Strong Buy
Analyst Count
20
9
Target Price
$238.20
$189.78
AVG Volume (30 Days)
7.7M
5.1M
Earning Date
04-14-2026
04-22-2026
Dividend Yield
2.36%
3.61%
EPS Growth
90.50
60.62
EPS
4.41
3.36
Revenue
N/A
$40,648,000,000.00
Revenue This Year
$6.63
$10.54
Revenue Next Year
$7.43
$6.65
P/E Ratio
$58.91
$55.42
Revenue Growth
N/A
7.31
52 Week Low
$172.72
$142.11
52 Week High
$274.90
$207.76

Technical Indicators

Market Signals
Indicator
JNJ
PM
Relative Strength Index (RSI) 50.94 46.54
Support Level $247.97 $182.29
Resistance Level $272.16 $190.25
Average True Range (ATR) 5.38 4.29
MACD -0.68 -1.16
Stochastic Oscillator 25.31 6.29

Price Performance

Historical Comparison
JNJ
PM

About JNJ Johnson & Johnson

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.

About PM Philip Morris International Inc

Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heat sticks, vapes, and oral nicotine offerings, primarily outside of the US. With the 2023 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI is not only dominant in smokable products but also has the Iqos and Zyn brands, which respectively dominate heated tobacco and nicotine pouches in most markets. It also owns the Veev brand in vapes.

Share on Social Networks: